Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states
Seek urgent medical attention (contact 111 or attend A&E) if you develop: Severe, sudden-onset headache ("thunderclap" pattern) unlike any previous headache Headache with fever, rash, or altered consciousness Persistent vomiting preventing fluid intake or medicine absorption Visual changes including double vision, blind spots, or temporary vision loss Signs of severe dehydration (dark urine, dizziness on standing, reduced urination) Symptoms suggesting pancreatitis (severe upper abdominal pain radiating to the back) Symptoms suggesting gallbladder problems (right upper abdominal pain, fever, yellowing of skin/eyes) Your healthcare provider needs to assess whether headaches represent a straightforward medicine side effect or indicate a more complex issue
The tool aims to reduce administrative burdens on physicians and improve efficiency
Tirzepatides dual-action mechanism, targeting both GLP-1 and GIP receptors, offers broader metabolic benefits, which may contribute to greater and more sustained weight loss compared to Semaglutide GLP-1, which primarily targets GLP-1 receptors
If meals stay consistent and fluid intake is adequate, energy stabilizes faster than waiting it out
